Ct. Guy et al., E2F-1 BLOCKS TERMINAL DIFFERENTIATION AND CAUSES PROLIFERATION IN TRANSGENIC MEGAKARYOCYTES, Molecular and cellular biology, 16(2), 1996, pp. 685-693
The transcription factor E2F-1 plays a central role in the cell cycle
through its ability to activate genes involved in cell division. E2F-1
activity is regulated by a number of proteins, including the retinobl
astoma susceptibility gene product, cyclin-dependent kinases, and thei
r inhibitors, proteins that have been implicated in the control of cer
tain developmental processes. To investigate a potential role of E2F-1
in differentiation, we assayed the ability of megakaryocytes to form
platelets in an in vivo transgenic model. E2F-1 expression in megakary
ocytes blocked differentiation during maturation, resulting in severe
thrombocytopenia. Ultrastructural analysis of megakaryocytes revealed
abnormal development characterized by hyperdemarcation of cytoplasmic
membranes and reduced numbers of alpha granules. Administration of meg
akaryocyte growth and development factor or interleukin 6 could not ov
ercome the differentiation block. Additionally, E2F-1 caused massive m
egakaryocyte accumulation in both normal and ectopic sites, first evid
ent in E15 embryonic liver. Furthermore, significant apoptosis was obs
erved in transgenic megakaryocytes. These data indicate that E2F-1 can
prevent terminal differentiation, probably through its cell cycle-sti
mulatory activity.